Shreveport, LOUISIANA2 Active Studies

Advanced Solid Tumors Clinical Trials in Shreveport, LOUISIANA

Find 2 actively recruiting advanced solid tumors clinical trials in Shreveport, LOUISIANA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
620
Enrolling

Recruiting Advanced Solid Tumors Studies in Shreveport

About Advanced Solid Tumors Clinical Trials in Shreveport

Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.

There are currently 2 advanced solid tumors clinical trials recruiting participants in Shreveport, LOUISIANA. These studies are seeking a combined 620 participants. Research is being sponsored by AstraZeneca, Merck Sharp & Dohme LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Advanced Solid Tumors Clinical Trials in Shreveport — FAQ

Are there advanced solid tumors clinical trials in Shreveport?

Yes, there are 2 advanced solid tumors clinical trials currently recruiting in Shreveport, LOUISIANA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Shreveport?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Shreveport research site will contact you about next steps.

Are clinical trials in Shreveport free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Shreveport studies also compensate for your time and travel.

What advanced solid tumors treatments are being tested?

The 2 active trials in Shreveport are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.

Data updated March 2, 2026 from ClinicalTrials.gov